
Georgios Angelidakis
@gioage
UT MD Anderson Cancer Center #ChemalyTeam
ID: 93307169
29-11-2009 02:26:06
10 Tweet
71 Followers
355 Following

Our mentor, Dr. Chemaly’s educational session! Really helpful to understand TB screening prior to immunosuppression! Dr Roy Chemaly #IDWeek2022 #TxID Infectious Diseases Community of Practice - AST MD Anderson Cancer Center @ruvandhi



What an incredible honour meeting in person the scientific leader and the great mind who helped Greece navigate the COVID19 pandemic Sotirios Tsiodras! Proud moment with Georgios Angelidakis @IDWeek2022


In this ASTCT Talks episode, Dr. Steven Pergam talks with Dr. Amy Spallone and Dr. Emily Ford to discuss #Monkeypox in #HCT and #CART. Listen here: ow.ly/hq8o50Lq9ez @PergamIC emily ford


Our MD Anderson Cancer Center ID mentor, Dr Roy Chemaly received the PRS Hassenbusch award 2022! Congratulations, Dr. Chemaly! 🎉


Learning about “New drugs and tools in CMV” from Dr.Dr Roy Chemaly at the 4th symposium of infections in the Immunocompromised host MD Anderson Cancer Center UTHealth Houston Infectious Diseases Takahiro Matsuo (Taka), MD Georgios Angelidakis


Team MD Anderson ID in Seattle! MD Anderson Cancer Center HutchIDSciences @UT_Infectious #IDSymp23 BCM ID Fellowship Anthony J. Febres A. 🔬🦠🎹 Rita Wilson Dib Khalis Mustafayev MD, PhD Inderjit Mann Georgios Angelidakis Dr Roy Chemaly @Teny_MJ


【Advances in Fecal Microbiota Transplantation for the Eradication of MDRO and Treatment of GVHD】 Interesting novel topic by Dr. Julian Marchesi, Imperial College London🇬🇧 👉academic.oup.com/cid/article/72… HutchIDSciences Fred Hutch Cancer Center #IDSymp23


I have the best team to work with👍 that is how it can be done @A_Spallonii Layale Yaghi Fareed Khawaja Georgios Angelidakis Rita Wilson Dib Anthony J. Febres A. 🔬🦠🎹 Takahiro Matsuo (Taka), MD Marilyne Daher Joseph Sassine and many more!!!

Thank you @A_Spallonii . It is a real honor and privilege to be selected to lead such a great department at The #1 cancer institution!!! MD Anderson Cancer Center. We still have a long road ahead of us to make a difference in the life of the most vulnerable patients that we care for!